Keyword Technology Search Result
PLX-51107 by Plexxikon for Graft Versus Host Disease (GVHD): Likelihood of Approval
PLX-51107 is under clinical development by Plexxikon and currently in Phase II for Graft Versus Host Disease (GVHD). According to GlobalData, Phase II drugs for Graft Versus Host Disease (GVHD) have a
Website link :https://adquash.com/news_q.php?str=PLX-51107_by_Plexxikon_for_Graft_Versus_Host_Disease_(GVHD):_Likelihood_of_Approval_1182
NKX-019 by Nkarta for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
NKX-019 is under clinical development by and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData, Phase I drugs for Diffuse Large B-Cell Lymphoma have a 78% phase transitio
Website link :https://adquash.com/news_q.php?str=NKX-019_by_Nkarta_for_Diffuse_Large_B-Cell_Lymphoma:_Likelihood_of_Approval_709
Honor 100 Pro Full Specifications, Features, Price In Philippines
The Honor 100 Pro was officially announced on November 23, 2023. The 5G-ready smartphone is fueled with a non-removable Li-Po 5000 mAh battery + 100W wired + 66W wireless + 5W reverse wired + Reverse
Website link :https://adquash.com/news_q.php?str=Honor-100-Pro-Full-Specifications-Features-Price-In-Philippines
NC-410 by NextCure for Endometrial Cancer: Likelihood of Approval
NC-410 is under clinical development by and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II drugs for Endometrial Cancer have a 22% phase transition success rate (PTSR)
Website link :https://adquash.com/news_q.php?str=NC-410_by_NextCure_for_Endometrial_Cancer:_Likelihood_of_Approval_903
XB-002 by Exelixis for Epithelial Ovarian Cancer: Likelihood of Approval
XB-002 is under clinical development by and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData, Phase II drugs for Epithelial Ovarian Cancer have a 38% phase transition succe
Website link :https://adquash.com/news_q.php?str=XB-002_by_Exelixis_for_Epithelial_Ovarian_Cancer:_Likelihood_of_Approval_904
NC-410 by NextCure for Ovarian Cancer: Likelihood of Approval
NC-410 is under clinical development by and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II drugs for Ovarian Cancer have a 26% phase transition success rate (PTSR) indicat
Website link :https://adquash.com/news_q.php?str=NC-410_by_NextCure_for_Ovarian_Cancer:_Likelihood_of_Approval_905
U.S. Hands Out First Space Debris Fine After Company Fails to Boost Satellite to Graveyard Orbit
The U.S. Federal Communications Commission (FCC) has handed out its first-ever space debris enforcement fine to a commercial company after television provider DISH Network failed to deorbit an ageing
Website link :https://adquash.com/news_q.php?str=U.S._Hands_Out_First_Space_Debris_Fine_After_Company_Fails_to_Boost_Satellite_to_Graveyard_Orbit_146
The Latest in All Things Automotive
The 2023 Los Angeles International Auto Show highlights all the latest advancements in the world of automotive. From what’s new in electrification, new models and special edition vehicles, to advanc
Website link :https://adquash.com/news_q.php?str=The_Latest_in_All_Things_Automotive_1231
Lenovo M10 Plus Full Specifications, Features, Price In Philippines
The Lenovo M10 Plus was officially announced on March 27, 2020. The tablet is fueled with a non-removable Li-Po 5000 mAh battery + 10W wired charging. It was launched in a single color, Iron Grey. Bod
Website link :https://adquash.com/news_q.php?str=Lenovo-M10-Plus-Full-Specifications-Features-Price-In-Philippines
NVDA Stock Price Prediction: Will Nvidia Break $600?
Against a soft backdrop on Wall Street Monday, shares of technology stalwart Nvidia (NASDAQ: NVDA ) helped brighten the atmosphere. Specifically, the smiles came courtesy of Goldman Sachs, which added
Website link :https://adquash.com/news_q.php?str=NVDA_Stock_Price_Prediction:_Will_Nvidia_Break_$600_76
Stellaris Changing Dimensions With Narrative-Driven Expansion
The universe has never felt bigger. Prepare for not one, but many dimensions to expand before you. Reality-breaking technology, alternate dimensions, and mind-bending phenomena await. Today, Paradox I
Website link :https://adquash.com/news_q.php?str=Stellaris_Changing_Dimensions_With_Narrative-Driven_Expansion_509
